CYPH — CYPHERPUNK TECHNOLOGIES INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1509745 ·
Last close
$2.81
Market Cap
$302.82M
52W High
$4.19
52W Low
$0.39
ADV30
16,906,540
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -4,689,000 | 39,389,000 | 142,969,000 | 7,624,000 | 3,650,000 |
| Mar 2026 | 0 | — | -4,817,000 | -77,166,000 | 87,378,000 | 6,689,000 | 3,003,000 |
| Dec 2025 | 0 | — | -5,260,000 | 40,203,000 | 163,182,000 | 14,035,000 | 9,676,000 |
| Sep 2025 | 0 | — | -3,222,000 | -3,303,000 | 11,399,000 | 9,686,000 | 8,704,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-32,852,000
Investing CF
$-9,000,000
Financing CF
$112,785,000
CapEx
$-4,000,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.31
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-539,715,000
Inventory
—
Receivables
$74,465,000
ST Investments
—
EBIT TTM
$-56,747,000
Pretax Income TTM
$-56,772,000
Interest Exp TTM
$25,000
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -36,697,000 | 4,822,000 | 163,182,000 | 9,676,000 | 153,506,000 | -43,902,000 |
| Dec 2024 | 0 | -70,057,000 | -67,555,000 | 49,124,000 | 14,076,000 | 35,048,000 | -60,299,000 |
| Dec 2023 | 0 | -85,940,000 | -81,414,000 | 72,825,000 | 12,684,000 | 60,141,000 | -43,753,000 |
| Dec 2022 | 0 | -54,712,000 | -54,596,000 | 70,353,000 | 11,487,000 | 58,866,000 | -49,044,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-56,909,000
OpCashFlow TTM
—
Assets (Latest)
$87,378,000
Forward EPS
$-0.09
Max Pain — expiry 2026-10-16
max pain strike: $2.50 · spot: $2.88 · call oi: 23,327 · put oi: 7,873
Expected Move to 2026-10-16:
±$0.47
(16.49%) —
implied range
$2.41 –
$3.36
· ATM straddle on $3.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | $300.60M | $8.75 | — |
| CATX | Perspective Therapeutics, Inc. | $309.35M | $2.71 | — |
| INDP | Indaptus Therapeutics, Inc. | $315.78M | $2.37 | — |
| RCKT | ROCKET PHARMACEUTICALS, INC. | $288.71M | $2.63 | — |
| FULC | Fulcrum Therapeutics, Inc. | $286.11M | $3.75 | — |
News headlines (Yahoo Finance, 1h cache)
Another Zcash ETF Is Coming: Winklevoss Twins File for 'WINK'
2026-10-06 18:42 · Yahoo
Winklevoss Zcash ETF Could Become the Second U.S. Spot ZEC Fund After Grayscale’s ZCSH
2026-10-06 16:45 · Yahoo
Winklevoss-Backed Cypherpunk Launches 'World's Largest' Zcash Mining Fleet
2026-08-19 09:31 · Yahoo
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
2026-08-12 11:00 · Yahoo
Winklevoss-Backed Zcash Treasury Plunges Nearly 40% on ZEC Privacy Bug Concerns
2026-06-05 15:49 · Yahoo
Winklevoss Twins To Launch New Zcash ETF
2026-10-07 14:01 · Yahoo
The Winklevoss Twins Plan to Invest $100 Million in the Coin That Outperformed Bitcoin
2026-10-06 22:51 · Yahoo
Crypto Exchange Gemini Switches Zcash Software
2026-09-30 13:47 · Yahoo
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
2026-09-25 03:23 · Yahoo
Zcash Outpaces Bitcoin Gains as Key Development Team Raises $25 Million
2026-03-09 20:19 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.